Article ID Journal Published Year Pages File Type
5701182 European Journal of Surgical Oncology (EJSO) 2016 11 Pages PDF
Abstract
Although adverse patient and tumor characteristics were not equally balanced between treatment arms, our systematic review and meta-analysis supports similar oncological outcomes between SU and RNU, with better preservation of renal function after SU. As such, SU should be preferably used as the first-line treatment for low-risk ureter tumors, while considered for selected cases of high-risk disease.
Related Topics
Health Sciences Medicine and Dentistry Oncology
Authors
, , , , , , , , , ,